Ocular Therapeutix (OCUL) Assets (2016 - 2025)
Historic Assets for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $808.1 million.
- Ocular Therapeutix's Assets rose 7645.67% to $808.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $808.1 million, marking a year-over-year increase of 7645.67%. This contributed to the annual value of $808.1 million for FY2025, which is 7645.67% up from last year.
- Per Ocular Therapeutix's latest filing, its Assets stood at $808.1 million for Q4 2025, which was up 7645.67% from $410.9 million recorded in Q3 2025.
- Ocular Therapeutix's 5-year Assets high stood at $808.1 million for Q4 2025, and its period low was $122.6 million during Q2 2023.
- In the last 5 years, Ocular Therapeutix's Assets had a median value of $236.9 million in 2021 and averaged $315.6 million.
- As far as peak fluctuations go, Ocular Therapeutix's Assets tumbled by 3147.23% in 2023, and later surged by 32191.53% in 2024.
- Ocular Therapeutix's Assets (Quarter) stood at $204.9 million in 2021, then fell by 27.14% to $149.3 million in 2022, then skyrocketed by 68.84% to $252.1 million in 2023, then skyrocketed by 81.68% to $457.9 million in 2024, then skyrocketed by 76.46% to $808.1 million in 2025.
- Its Assets stands at $808.1 million for Q4 2025, versus $410.9 million for Q3 2025 and $451.3 million for Q2 2025.